Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Deterioration in renal function associated with fibrate therapy.

J Lipscombe1, G F Lewis, D Cattran

  • 1Division of Nephrology, University Health Network, Toronto, Canada.

Clinical Nephrology
|February 24, 2001
PubMed
Summary

Fibrate medications, used for high cholesterol, can cause temporary kidney function decline in patients with pre-existing renal issues. This reversible effect highlights the need for caution when prescribing fibrates to at-risk individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single cell RNA-sequencing and RNA-tomography of the avian embryo extending body axis.

Frontiers in cell and developmental biology·2024
Same author

Chromosome-level genome sequence of the Genetically Improved Farmed Tilapia (GIFT, Oreochromis niloticus) highlights regions of introgression with O. mossambicus.

BMC genomics·2022
Same author

Phase 2 of the Norwich COVID-19 testing initiative: an evaluation.

Journal of public health (Oxford, England)·2021
Same author

Norwich COVID-19 testing initiative pilot: evaluating the feasibility of asymptomatic testing on a university campus.

Journal of public health (Oxford, England)·2020
Same author

Cosmological Constraints from Multiple Probes in the Dark Energy Survey.

Physical review letters·2019
Same author

Peritonitis caused by veillonella species and Eggerthella lenta in peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2014

Area of Science:

  • Nephrology
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Fibric acid derivatives (fibrates) are widely prescribed for hyperlipidemia.
  • A potential, under-recognized side effect of fibrates is renal function impairment.
  • This study investigates fibrate-induced changes in kidney function.

Purpose of the Study:

  • To review cases of renal function deterioration associated with fibrate therapy.
  • To identify patient characteristics and potential mechanisms underlying this adverse effect.

Main Methods:

  • Retrospective chart review of 10 patients experiencing renal function changes.
  • Data collected included serum creatinine, urea, cyclosporine levels, and medical history.
  • Analysis focused on identifying confounding factors for altered renal function.

Related Experiment Videos

Main Results:

  • Ten male patients with pre-existing renal insufficiency showed elevated creatinine and urea levels during fibrate treatment.
  • Creatinine levels significantly increased (p < 0.001) but returned to baseline after fibrate discontinuation.
  • No changes in cyclosporine levels or creatine kinase were observed.

Conclusions:

  • Fibrate therapy can lead to reversible renal function deterioration in susceptible individuals.
  • The exact mechanism remains unclear, but renal hemodynamics are a plausible explanation.
  • Caution is advised when prescribing fibrates to patients with existing kidney dysfunction.